Preliminary economic feasibility study of MIP (Medical Isotopes Producer)

Preliminary economic feasibility study of MIP (Medical Isotopes Producer), which is used liquid nuclear fuel to produce medical isotopes of Mo-99 and Sr-89, was performed. To do this, this study was estimated the IRR(Internal Rate of Return) and PBP(Pay-back Period) about optimistic and pessimistic cases for market penetration of Asia and U.S.A. isotope markets. And sensitivity analysis is also performed about capital cost and price of Mo-99 and Sr-89. According to the results, IRR was between 14.9% and 24.3%, and PBP was between 4.8 years and 7.8 years. These suggest that MIP has economic merits. MIP can produce other medical isotopes such as Sr-90, I-131, Xe-133, Cs-137. So, it is necessary to do cost-benefit analysis considering production of these other isotopes